## Abstract The highly potent serotonin (5‐HT) uptake blocker, McN‐5652‐Z (__trans__‐1,2,3,5,6,10b ‐ hexahydro ‐ 6 ‐ [4 ‐ (methylthio)phenyl] pyrrolo ‐ [2,1‐a]‐isoquinoline) was labeled with ^11^C for studying serotonin uptake sites using positron emission tomography (PET). [^11^C]McN‐5652‐Z was sy
Synthesis of the racemate and individual enantiomers of [11C]methylphenidate for studying presynaptic dopaminergic neuron with positron emission tomography
✍ Scribed by Y.-S. Ding; Y. Sugano; J. S. Fowler; C. Salata
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 501 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Carbon‐11 labeled dl‐threo‐methylphenidate (methyl‐2‐phenyl‐2‐(2‐piperidyl)acetate, Ritalin), a psychostimulant drug widely used to treat attention deficit hyperactivity disorder, was prepared in two steps: O‐methylation of the N‐protected dl‐threo‐ritalinic acid derivative with [^11^C]methyl iodide followed by deprotection. The same strategy was applied for the preparation of C‐11 labeled individual enantiomers of threo‐methylphenidate from N‐protected d‐threo‐ or l‐threo‐ritalinic acid. The subsequent C 18 sep‐pak and reverse‐phase HPLC purification resulted in ca. 40% radiochemical yield with a total synthesis time of 40 minutes and an average specific activity of 1.5 Ci/μmole (at EOB).
📜 SIMILAR VOLUMES
Dexetimide (Fig. la), a potent muscarinic cholinergic receptor antagonist, and levetimide (Fig. lb), its pharmacologically inactive enantiomer, were labeled with "C for non-invasive in vivo studies of muscarinic cholinergic receptors in the human brain using positron emission tomography. The synthes